Weekly Companion Animal News: April 6, 2026
Purina Pet Care Innovation Prize awarded to PetPax for thin-film delivery method for supplements
Pet Pax Co., maker of SupplaMelts, a fast-dissolving oral thin-film delivery method for veterinarian-approved supplements, was selected as grand prize winner of the 2026 Pet Care Innovation Prize, supported by Purina’s 9Square Ventures group and Active Capital. Four other companies received awards and mentorships: ChewPaw, provider of personalized nutrition; CoVetAI Inc., a veterinary clinical copilot; Innovative Pet Lab Inc., developer of non-invasive home testing; and Pawsitive Inc., developer of a smart wearable to monitor dogs’ emotions and behavior.
Studies investigate how clients experience pet loss, and how vets can support them
Two studies from the Dog Aging Project suggest that while the circumstances surrounding a dog’s death may vary, the emotional impact on owners remains strikingly similar, including grief, guilt and blame. Both studies highlight several opportunities for veterinarians to improve communication with pet owners about aging, quality of life and end-of-life care, and to recognize the emotional impact of pet loss on their clients. The work reinforces the idea that veterinary care extends beyond treating animals to also supporting the people who care for them.
New antibiotics alone won’t solve drug-resistant problem
Newer antibiotics designed for drug-resistant bacterial infections are being used more frequently but aren’t making a dent in survival rates, according to a study published in The Lancet Infectious Diseases. Among patients hospitalized with a difficult-to-treat (DTR) gram-negative bacterial infection, initial treatment with one of six antibiotics approved in recent years rose by nearly 300% from 2016 to 2023, but there was no observed reduction in mortality among them. Furthermore, more than three-quarters of the received initial treatment with discordant antibiotics, i.e., antibiotics that either weren’t active against the pathogen or to which the pathogen was actively resistant.
Optiscan (Australia) takes step toward US veterinary market
Optiscan, a Melbourne, Australia-based imaging company, submitted a regulatory dossier to the US FDA Center for Veterinary Medicine for its InSpecta device, designed to offer real-time, microscopic imaging in animal care settings. The submission demonstrates the company’s ability to move a product through the full development lifecycle, from concept to regulatory review, and positions Optiscan to expand its network of U.S. veterinary referral hospitals, specialty oncology centers and corporate clinics.
Spot Pet Insurance survey exposes a ‘hard affordability line’
In the company’s 2026 Pet Parent Perspective, 21% of respondents said $500 marks the exact point where a vet bill moves from ‘doable’ to ‘I physically cannot pay this.’ In another finding, 31% of survey respondents said that a partner refusing to pay an expensive treatment ($7,000+) for a pet’s life-saving surgery would end the relationship. Fifteen percent report they were forced to choose euthanasia due to the cost of a vet bill, and 4% report liquidating a 401(k) or emergency fund to avoid saying goodbye to a pet due to a vet bill.
Virginia bill would match up shelters and veterinarians
A Virginia bill – HB1287 – proposes that veterinarians would be asked when applying for or renewing their license if they’re willing to work with shelters. That information would then be shared with organizations in need. The bill passed unanimously in the General Assembly and now heads to the governor’s desk with a decision expected by mid-April.
Optiscan (Australia) takes step toward US veterinary market
Optiscan, a Melbourne, Australia-based imaging company, submitted a regulatory dossier to the US FDA Center for Veterinary Medicine for its InSpecta device, designed to offer real-time, microscopic imaging in animal care settings. The submission demonstrates the company’s ability to move a product through the full development lifecycle, from concept to regulatory review, and positions Optiscan to expand its network of U.S. veterinary referral hospitals, specialty oncology centers and corporate clinics.
Vetology updates radiology screening reports
Vetology, a provider of AI-generated radiology screening reports and board-certified veterinary teleradiology, expanded its publicly available AI performance dashboard from four metrics per classifier to eleven. New classifiers include Obscuring Pleural Effusion, Esophageal Enlargement, Intervertebral Disc Disease (Thoracic), Small Intestine Enlargement (Feline), Colon Diffuse Distension (Feline), and a consolidated Heart Failure classifier for canine imaging.
